Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Related Posts
States Are Stepping Up as the New Antitrust Enforcers
With the Trump administration taking a relaxed approach, attorneys general around the country have ramped up their scrutiny of mergers.
The Business Playbook for Tariff Chaos
President Trump’s trade war is forcing companies to cut costs, raise prices, shrink profits, discontinue products and find other suppliers.
In the Protein Era, Even He-Man Is Hawking Supplements
To promote “Masters of the Universe,” Mattel, the toymaker behind the movie, tapped into one of the hottest trends in…